Paul Singer Catalent, Inc. Transaction History
Elliott Investment Management L.P.
- $16.7 Billion
- Q2 2024
A detailed history of Paul Singer (Elliott Investment Management L.P.) transactions in Catalent, Inc. stock. As of the latest transaction made, Elliott Investment Management L.P. holds 4,000,000 shares of CTLT stock, worth $235 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
4,000,000
Previous 4,000,000
-0.0%
Holding current value
$235 Million
Previous $226 Million
0.39%
% of portfolio
1.34%
Previous 1.47%
Shares
1 transactions
Others Institutions Holding CTLT
# of Institutions
486Shares Held
160MCall Options Held
364KPut Options Held
837K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$901 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$645 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$431 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$291 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.6B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...